It has been suggested that adiponectin, an anti-inflammatory substance, is decreased in subjects presenting with high levels of visceral fat, which can in turn lead to inflammation-induced microalbuminuria and cardiovascular disease [28]. Here, ADIPOQ is linked to cardiovascular disorder.